Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Alterations of Blood Flow Through Arteries Following Atherectomy and the Impact on Pressure Variation and Velocity.

Plourde BD, Vallez LJ, Sun B, Nelson-Cheeseman BB, Abraham JP, Staniloae CS.

Cardiovasc Eng Technol. 2016 Jun 22. [Epub ahead of print]

PMID:
27333887
2.

Physiologic Guidance of Infrainguinal Vascular Interventions Using the Pressure Wire.

Staniloae CS, Vales L, Han SY, Sloves J, Fallahi A.

J Invasive Cardiol. 2015 Oct;27(10):483-8.

3.

Evaluating patent ductus arteriosus during percutaneous closure: correlation between intravascular ultrasonography and computed tomographic angiography.

LaBarbera M, Storch BM, Staniloae CS, Slater J.

Tex Heart Inst J. 2014 Apr 1;41(2):238-9. doi: 10.14503/THIJ-12-2914. eCollection 2014 Apr. No abstract available.

4.

Orbital atherectomy: device evolution and clinical data.

Staniloae CS, Korabathina R.

J Invasive Cardiol. 2014 May;26(5):215-9. Review.

5.

Transradial access for peripheral vascular interventions.

Staniloae CS, Korabathina R, Coppola JT.

Catheter Cardiovasc Interv. 2013 Jun 1;81(7):1194-203. doi: 10.1002/ccd.24608. Epub 2013 Feb 12. Review.

PMID:
22899648
6.

Commentary: the new state of the art in endovascular treatment of chronic mesenteric ischemia.

Staniloae CS.

J Endovasc Ther. 2012 Aug;19(4):495-6. doi: 10.1583/19-4_12-3900C.1. No abstract available.

PMID:
22891828
7.

Endoluminal treatment of peripheral chronic total occlusions using the Crosser® recanalization catheter.

Staniloae CS, Mody KP, Yadav SS, Han SY, Korabathina R.

J Invasive Cardiol. 2011 Sep;23(9):359-62.

8.

Study to determine the clinical significance of HEmolysis During Orbital AtheRectomy (CLEAR study).

Staniloae CS, Korabathina R, Lane TA, Dattilo R, Church KJ, Mody KP, Mayeda GS.

J Endovasc Ther. 2011 Feb;18(1):57-63. doi: 10.1583/10-3179.1.

PMID:
21314350
9.

Optimal techniques with the Diamondback 360° System achieve effective results for the treatment of peripheral arterial disease.

Adams GL, Khanna PK, Staniloae CS, Abraham JP, Sparrow EM.

J Cardiovasc Transl Res. 2011 Apr;4(2):220-9. doi: 10.1007/s12265-010-9255-x. Epub 2011 Feb 11. Review.

PMID:
21312013
10.

Transradial peripheral vascular interventions.

Coppola JT, Kurian DC, Staniloae CS.

Indian Heart J. 2010 May-Jun;62(3):197-201. Review.

PMID:
21275291
11.

Orbital atherectomy for symptomatic lower extremity disease.

Korabathina R, Mody KP, Yu J, Han SY, Patel R, Staniloae CS.

Catheter Cardiovasc Interv. 2010 Sep 1;76(3):326-32. doi: 10.1002/ccd.22508.

PMID:
20839344
12.

Transradial approach to lower extremity interventions.

Korabathina R, Yadav SS, Coppola JT, Staniloae CS.

Vasc Health Risk Manag. 2010 Aug 9;6:503-9. Review.

13.

Safety and efficacy of transradial aortoiliac interventions.

Staniloae CS, Korabathina R, Yu J, Kurian D, Coppola J.

Catheter Cardiovasc Interv. 2010 Apr 1;75(5):659-62. doi: 10.1002/ccd.22348.

PMID:
20088010
14.

Histopathologic changes of the radial artery wall secondary to transradial catheterization.

Staniloae CS, Mody KP, Sanghvi K, Mindrescu C, Coppola JT, Antonescu CR, Shah S, Patel T.

Vasc Health Risk Manag. 2009;5(3):527-32. Epub 2009 Jun 29.

15.

Contrast-induced nephropathy and long-term adverse events: cause and effect?

Solomon RJ, Mehran R, Natarajan MK, Doucet S, Katholi RE, Staniloae CS, Sharma SK, Labinaz M, Gelormini JL, Barrett BJ.

Clin J Am Soc Nephrol. 2009 Jul;4(7):1162-9. doi: 10.2215/CJN.00550109. Epub 2009 Jun 25.

16.

N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study.

Staniloae CS, Doucet S, Sharma SK, Katholi RE, Mody KR, Coppola JT, Solomon R.

J Interv Cardiol. 2009 Jun;22(3):261-5. doi: 10.1111/j.1540-8183.2009.00456.x. Epub 2009 Mar 13.

PMID:
19490358
17.

Ranolazine improves endothelial function in patients with stable coronary artery disease.

Deshmukh SH, Patel SR, Pinassi E, Mindrescu C, Hermance EV, Infantino MN, Coppola JT, Staniloae CS.

Coron Artery Dis. 2009 Aug;20(5):343-7. doi: 10.1097/MCA.0b013e32832a198b.

PMID:
19444092
18.

Pioglitazone increases adiponectin levels in nondiabetic patients with coronary artery disease.

Patel SR, Mailloux LM, Coppola JT, Mindrescu C, Staniloae CS.

Coron Artery Dis. 2008 Aug;19(5):349-53. doi: 10.1097/MCA.0b013e3282fd5c37.

PMID:
18580598
19.

Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.

Nissen SE, Nicholls SJ, Wolski K, Nesto R, Kupfer S, Perez A, Jure H, De Larochellière R, Staniloae CS, Mavromatis K, Saw J, Hu B, Lincoff AM, Tuzcu EM; PERISCOPE Investigators.

JAMA. 2008 Apr 2;299(13):1561-73. doi: 10.1001/jama.299.13.1561. Epub 2008 Mar 31.

PMID:
18378631
20.

Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia.

Mindrescu C, Gupta RP, Hermance EV, DeVoe MC, Soma VR, Coppola JT, Staniloae CS.

Vasc Health Risk Manag. 2008;4(6):1439-47.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk